View Older Stories View More Recent Stories
-
Form 13F-HR Broadfin Capital, LLC For: Sep 30
-
Cidara Therapeutics (CDTX) Prices $20M Private Placement of Common Stock
-
Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
-
Form 13F-HR/A Broadfin Capital, LLC For: Jun 30
-
Form 13F-HR Broadfin Capital, LLC For: Jun 30
-
Form SC 13G Regulus Therapeutics Filed by: Broadfin Capital, LLC
-
Form SC 13G Cidara Therapeutics, Filed by: Broadfin Capital, LLC
-
PlacementTracker Publishes First Half 2017 PIPE Market League Tables
-
Form SC 13G/A Corium International, Filed by: Broadfin Capital, LLC
-
Form 13F-HR Broadfin Capital, LLC For: Mar 31
-
Form SC 13G/A ARATANA THERAPEUTICS, Filed by: Broadfin Capital, LLC
-
Form SC 13G Alphatec Holdings, Inc. Filed by: Broadfin Capital, LLC
-
Form 13F-HR Broadfin Capital, LLC For: Dec 31
-
Form SC 13G/A ANGIODYNAMICS INC Filed by: Broadfin Capital, LLC
-
Form SC 13G/A ALCOBRA LTD. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Aralez Pharmaceuticals Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Aviragen Therapeutics, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A AmpliPhi Biosciences Filed by: Broadfin Capital, LLC
-
Form SC 13G/A ARATANA THERAPEUTICS, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
-
Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Ignyta, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A VERACYTE, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Aevi Genomic Medicine, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A BioLineRx Ltd. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A NEVRO CORP Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Egalet Corp Filed by: Broadfin Capital, LLC
-
Form SC 13G/A CATALYST PHARMACEUTICALS Filed by: Broadfin Capital, LLC
-
Form SC 13G/A ADMA BIOLOGICS, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A ANTARES PHARMA, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A RXi Pharmaceuticals Corp Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Advaxis, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A HERON THERAPEUTICS, INC. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Lion Biotechnologies, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A CONTRAFECT Corp Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Corium International, Filed by: Broadfin Capital, LLC
-
Form SC 13G/A NOVADAQ TECHNOLOGIES Filed by: Broadfin Capital, LLC
-
Form SC 13G/A CAS MEDICAL SYSTEMS INC Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Tonix Pharmaceuticals Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Nexvet Biopharma plc Filed by: Broadfin Capital, LLC
-
Form SC 13G/A RedHill Biopharma Ltd. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Horizon Pharma plc Filed by: Broadfin Capital, LLC
-
Form SC 13G/A RITTER PHARMACEUTICALS Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Retrophin, Inc. Filed by: Broadfin Capital, LLC
-
Form SC 13G/A TITAN PHARMACEUTICALS Filed by: Broadfin Capital, LLC
-
Form SC 13G/A SCYNEXIS INC Filed by: Broadfin Capital, LLC
-
Form SC 13G/A Strongbridge Biopharma Filed by: Broadfin Capital, LLC
-
Form SC 13G/A SeaSpine Holdings Corp Filed by: Broadfin Capital, LLC
-
Form SC 13G WINDTREE THERAPEUTICS Filed by: Broadfin Capital, LLC
-
Form SC 13G/A KEMPHARM, INC Filed by: Broadfin Capital, LLC

